I want to link it to the other question too. There are elements that we can learn around surveillance that I think Bruce has alluded to that have been a standard in public health. We do select doctors and nurses and pharmacists to report. We train them up. Sometimes it's on how much measles is going on or how much pneumonia they're seeing. What we haven't done is train up our professionals to do this in such a robust way. It's partially because people don't see a circle. They see a black hole.
The other piece that I think you've had before you is the proposal for the drug research and effectiveness network, which would be tasked with the job of developing how to synthesize this information, how to do the follow-up studies of the kind that Bruce is involved with and developing a hierarchy of needs. But I just can't stress enough that we need a framework going into it that will make sure that we're covering off the bases so that we are including sex and gender and we are including data on age at the beginning, otherwise we won't have it at the end and we'll be back here again just repeating the wheel.
I think those processes are in the planning stages, and I would urge you to bring Dr. Lee back.